Skip to content

Clinical trials

Glucose Metabolism Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Country / region: Germany Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20067
20071
20082
20092
20103
20141
20171
20181
20202
20211
20244
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting4
Recruiting2
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda11
AstraZeneca2
Pfizer2
Rezolute2
Ultragenyx Pharmaceutical Inc2
University of Ulm2
Beta-Stim Ltd.1
Charite University, Berlin, Germany1
Eli Lilly and Company1
Gaia AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders29
Diabetes Mellitus18
Diabetes Mellitus, Type 218
Dyslipidemias11
Metabolic Diseases11
Endocrine System Diseases7
Body Weight4
Diabetes Mellitus, Lipoatrophic4
Nutrition Disorders4
Obesity4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.